Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akinao Haba

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Intratumoral injection of immature dendritic cells (DC) for cancer patients]Tsutomu Takeda, Kaori Makita, Kazumi Okita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 11, 2007
[Successful immunotherapy combined with hyperthermia therapy for cancer patients]Tsutomu Takeda, Xianhui Dong, Hiroko Takeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]Tsutomu Takeda, Xianhui Dong, Hiroko Takeda, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2005
Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicinKen Shiozaki, Naoko Harada, William R Greco, et al.
Current Drug Delivery|November 2, 2010
Endoglin-targeted cancer therapyBen K Seon, Akinao Haba, Fumihiko Matsuno, et al.
Immunologic Research|September 19, 2009
Receptor-targeted anticancer therapyBen K Seon, Yuro Haruta, Fumihiko Matsuno, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Intratumoral injection of immature dendritic cells (DC) for cancer patients]Tsutomu Takeda, Kaori Makita, Kazumi Okita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 11, 2007
[Successful immunotherapy combined with hyperthermia therapy for cancer patients]Tsutomu Takeda, Xianhui Dong, Hiroko Takeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]Tsutomu Takeda, Xianhui Dong, Hiroko Takeda, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2005
Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicinKen Shiozaki, Naoko Harada, William R Greco, et al.
Current Drug Delivery|November 2, 2010
Endoglin-targeted cancer therapyBen K Seon, Akinao Haba, Fumihiko Matsuno, et al.
Immunologic Research|September 19, 2009
Receptor-targeted anticancer therapyBen K Seon, Yuro Haruta, Fumihiko Matsuno, et al.
Pageof 1